Characteristics | Healthy controls (n = 100) | CKDk patients (n = 100) | CKDu patients (n = 100) | One-way ANOVA | Significance |
---|---|---|---|---|---|
I | II | III | |||
Age (years) | 42.76 ± 12.6 | 43.73 ± 11.3 | 45.23 ± 12.5 | 0.135 | |
Sex (M/F) | 60:40 | 60:40 | 60:40 | ||
BMI (kg/m2) | 22.06 ± 1.8 | 21.94 ± 3.2 | 21.46 ± 2.1 | 0.621 | |
Blood pressure (mmHg) SBP | 119.07 ± 9.1 | 137.8 ± 15.2 | 128.8 ± 11.2 | 0.00* | I vs II = 0.000 |
I vs III = 0.000 | |||||
II vs III = 0.000 | |||||
Blood pressure (mmHg) DBP | 75.37 ± 4.4 | 90.6 ± 9.5 | 74.47 ± 7.3 | 0.00* | I vs II = 0.000 |
I vs III = 0.113 | |||||
II vs III = 0.001 | |||||
Fasting plasma glucose (mg/dL) | 91.83 ± 5.63 | 148.83 ± 5.23 | 92.10 ± 4.36 | 0.044* | I vs II = 0.000 |
I vs III = 0.999 | |||||
II vs III = 0.000 | |||||
Post prandial plasma glucose (mg/dL) | 119.2 ± 4.26 | 197.43 ± 6.38 | 115 ± 3.25 | 0.029* | I vs II = 0.000 |
I vs III = 0.903 | |||||
II vs III = 0.000 | |||||
Total cholesterol (mg/dL) | 160 ± 8.1 | 189.74 ± 16.5 | 190.9 ± 18.2 | 0.004* | I vs II = 0.000 |
I vs III = 0.684 | |||||
II vs III = 0.000 | |||||
Triglyceride (mg/dL) | 86.3 ± 6.9 | 148.28 ± 11.7 | 129.97 ± 16.8 | 0.001* | I vs II = 0.023 |
I vs III = 0.01 | |||||
II vs III = 0.04 | |||||
Total lipid (mg/dL) | 519.82 ± 25.6 | 600.52 ± 10.9 | 612.2 ± 11.5 | 0.005* | I vs II = 0.001 |
I vs III = 0.01 | |||||
II vs III = 0.04 | |||||
Blood urea (mg/dL) | 20.8 ± 4.7 | 65.5 ± 18.0 | 70.8 ± 18.8 | 0.000* | I vs II = 0.000 |
I vs III = 0.000 | |||||
II vs III = 0.097 | |||||
eGFR (mL/min/1.73 m2) | 99.2 ± 10.8 | 57.5 ± 9.4 | 59.3 ± 10.5 | 0.000* | I vs II = 0.004 |
I vs III = 0.001 | |||||
II vs III = 0.321 | |||||
Urinary albumin excretion mg/dL (24 h), median (25–75th percentile)a | 26.0 (22.0–30.0) | 850.0 (377.5–1925.0) | 870.0 (350.0–1630.0) | 0.008* | I vs II = 0.000 I vs III = 0.000 II vs III = 0.729 |